✦ LIBER ✦

Targeted agents for the systemic treatment of advanced hepatocellular carcinoma

✍ Scribed by Arun AZAD; Fiona CHIONH; Jonathan CEBON

Book ID: 111318742
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 132 KB
Volume: 5
Category: Article
ISSN: 1743-7555
DOI: 10.1111/j.1743-7563.2009.01202.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systemic treatment in advanced/metastati

Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy

✍ Kwang-Hyub Han; Jun Yong Park 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Targeted agents for the treatment of adv

Targeted agents for the treatment of advanced renal cell carcinoma

✍ Walter M. Stadler 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

Emerging strategies in the treatment of

Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies

✍ R. Lord; A. Suddle; P. J. Ross 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Management of advanced hepatocellular ca

Management of advanced hepatocellular carcinoma in the era of targeted therapy

✍ Thomas Yau; Pierre Chan; Richard Epstein; Ronnie Tung Ping Poon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Advancing the diagnosis and treatment of

Advancing the diagnosis and treatment of hepatocellular carcinoma

✍ J. Wallis Marsh; Sydney D. Finkelstein; Myron E. Schwartz; M. Isabel Fiel; Igor 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

We analyzed global gene expression patterns of 91 human hepatocellular carcinomas (HCCs) to define the molecular characteristics of the tumors and to test the prognostic value of the expression profiles. Unsupervised classification methods revealed two distinctive subclasses of HCC that are highly a

Randomized controlled trial of interfero

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

✍ Josep M. Llovet; Margarita Sala; Lluís Castells; Yanette Suarez; Ramon Vilana; L 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

The aim of this randomized controlled trial was to assess the efficacy of interferon alfa-2b (IFN) for the treatment of advanced hepatocellular carcinoma (HCC). Fifty-eight patients with HCC who were not suitable for resection, transplantation, ethanol injection, or arterial embolization were strati